Cognito Therapeutics Announces Spectris™ Treatment Demonstrates Myelin and Synaptic ...
Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced ...
Le Lézard11 小时
Cognito Therapeutics Announces Spectristm Treatment Demonstrates Myelin and Synaptic ...
Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the publication of a study in Alzheimer's & Dementia: Translational ...